Bioreactors Market Growing Technology Trends and Business Opportunities by 2025

The global bioreactors market size is estimated to expand at nearly 16.0 % CAGR from 2018 to 2025. The segmentation of global bioreactors industry is based on different types, product, scale, material, control type, application, end-user and geography. Different single-use bioreactors includes filtration assemblies, media bags and single use bioreactor systems. The single use bioreactor systems is expected to pick the pace in the coming next years. Media bags help forming attractive product segment which is projected to generate positive global bioreactors market share.

Request For Sample PDF Bioreactors Market Report: https://www.adroitmarketresearch.com/contacts/request-sample/710

In the contemporary scenario, adoption of single-use technologies, increasing biologics and use of single-use and stainless steel kind of hybrid technologies is expected to fuel the bioreactors market growth. Biopharmaceuticals have wide range of applications, beginning with production of biopharmaceutical to applications in tissue engineering. Besides that, bioreactors offer controllable environment, in terms of nutrient supply, pH temperature and shear stress for any cellular constructs incorporated into them. All these factors effectively enlarge global bioreactors market size. The consumption of biopharmaceutical products is expected to showcase a prominent increase in the region over the next few years. As a result, the processes used for manufacturing these products are required to meet the market demand.

The end-uses or applications that have supported strong bioreactors market trends include contract research organizations (CROs), biotechnology & pharmaceutical, and others. Contract research organizations (CROs) are a key constituent of the drug development process, providing a range of services to pharmaceutical, biotechnology, and medical device companies, as well as governments, academic institutions, and other research entities.

Single-use bioreactors are extensively used in CROs. CROs typically handle different products on account of which it is economical to use disposable bags in place of a stainless-steel vessel. The growing number of CROs is expected to augment the growth of the single use bioreactor market industry over the next few years.

U.S. was the largest market for biopharmaceuticals in North America. A large number of pipelines within the healthcare sector is expected to give rise to a large number of clinical trials which is likely to boost the global bioreactors market size by 2025. In addition, increasing trends of outsourcing by biopharma companies to CROs is expected to enhance the bioreactors market trends in the country, over the years ahead. North America and Europe are anticipated to portray strong bioreactors market trends during the forecast period.

Europe, Asia Pacific, North America, Latin America, and the Middle East and Africa are the most prominent regions for global bioreactors market. Europe ranked highest of global bioreactors market share. Europe government’s supporting policies catalyze biopharmaceutical companies to come up with some novel therapies in biologics, tuning the higher application of single-use bioreactors in cell culture-based manufacturing.

On the basis of material, the segmentation has two categories, glass and stainless steel. While in the basis of application, the categories include pilot-scale production, full-scale production and lab-scale production. In terms of scale, the market has wide range which includes 5L-20L, 20L-200L, 200L-1,500L, and above 1,500L. On the basis of control type, the market is bifurcated into automated and manual. On the basis of end-user, the market has categories which is inclusive of contract research organizations & manufacturers, biopharmaceutical manufacturers and life science R&D companies & academic research institutes

Prominent global bioreactors market players are Thermo Fisher Scientific, Inc. (U.S.), Sartorius AG (Germany), GE Healthcare (A subsidiary of General Electric Company) (U.S.), Merck KGaA (Germany), Eppendorf AG (Germany) and Danaher Corporation (U.S). Other major engineering, Procurement and Construction (EPC) players Fluor Corporation (U.S.), M+W Group (Germany), Technip S.A. (France), Amec Foster Wheeler plc (U.K.), Jacobs Engineering Group Inc. (U.S.) and PM Group (Ireland)

Key segments of the global bioreactors market trends for non-food applications:

Product Overview, 2012-2025 (USD Million)

• Single-use
• Multi-use

Construction Material Overview, 2012-2025 (USD Million)

• Stainless steel
• Glass
• Others

Application Overview, 2012-2025 (USD Million)

• Biotechnology & pharmaceutical
• Contract Research Organizations (CROs)
• Others

Regional Overview, 2012-2025 (USD Million)

• North America
• S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• South Korea
• Japan
• India
• Rest of Asia Pacific
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• South Africa
• Rest of MEA

About Adroit Market Research:

Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Information:

Ryan Johnson

Account Manager Global

3131 McKinney Ave Ste 600, Dallas,

TX75204, U.S.A.

Phone No.: USA: +1 (214) 884-6068 / +91 9665341414

Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018.